Related Experiment Video
Updated: Apr 16, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Drug therapy for the patient with resistant hypertension
Luca Donazzan1, Sebastian Ewen, Vasilios Papademetriou
1Klinik für Innere Medizin III (Kardiologie, Angiologie & Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, D-66421 Homburg/Saar, Germany.
Abstract:
Resistant hypertension is associated with high morbidity and mortality. Resistant hypertension is defined as blood pressure above targets despite treatment with at least three antihypertensive drugs in adequate dose and combination. Nonadherence is a frequent cause of uncontrolled hypertension and can be improved by providing fixed dose (of two or three agents) single pill combination. Triple combination of the most widely used antihypertensive agents (renin-angiotensin-aldosterone system antagonists, calcium channel blockers and diuretics) is a safe and effective therapy. Fourth line therapy is the use of an aldosterone antagonist. Renal denervation and baroreceptor stimulation can be considered in patients who remained uncontrolled despite optimal medical therapy.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure V: Medical Management
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics

